World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
45293
World Ranking
11541
National Ranking
1098

Overview

Gordon K. Wilcock is affiliated with the University of Oxford in the United Kingdom, contributing to the field of Medicine with a focus on multiple subfields including Psychiatry and Mental Health, Physiology, Neurology, Critical Care and Intensive Care Medicine, and Geriatrics and Gerontology.

Their research spans several topics related to neurological and cognitive health, including:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Neurological Disease Mechanisms and Treatments
  • Intensive Care Unit Cognitive Disorders
  • Frailty in Older Adults
  • Therapeutic Uses of Natural Elements
  • Body Contouring and Surgery

Notable recent papers authored or co-authored by Wilcock include:

  • Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT (2020), published in Efficacy and Mechanism Evaluation
  • Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study (2021), published in Health Services and Delivery Research
  • Mise à jour technique no 462: Marqueurs sériques maternels anormaux et issues défavorables de larossesse (2025), published in Journal of Obstetrics and Gynaecology Canada
  • Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes (2025), published in Journal of Obstetrics and Gynaecology Canada
  • Directive n° 465: Lésions obstétricales du sphincter anal (LOSA) Partie II: Prise en charge à long terme et conseils concernant le mode d'accouchement ultérieur (2025), published in Journal of Obstetrics and Gynaecology Canada

Wilcock has frequently published in several venues, including:

  • Journal of Obstetrics and Gynaecology Canada
  • Efficacy and Mechanism Evaluation
  • Health Services and Delivery Research

The scientist has collaborated often with several coauthors, including:

  • Elissa Cohen
  • Emanuel Felipe de Oliveira Filho
  • Megan Gomes
  • Sebastian R. Hobson
  • Kenneth Lim

Best Publications

  • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

    I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry

  • The cholinergic hypothesis of Alzheimer’s disease: a review of progress

    Paul T Francis;Alan M Palmer;Michael Snape;Gordon K Wilcock

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease

    R. C. A. Pearson;M. M. Esiri;R. W. Hiorns;G. K. Wilcock

  • Plaques, tangles and dementia. A quantitative study.

    G.K. Wilcock;M.M. Esiri

  • Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

    G.K. Wilcock;M.M. Esiri;D.M. Bowen;C.C.T. Smith

  • Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

    Robert C. Green;Lon S. Schneider;David A. Amato;Andrew P. Beelen

  • Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination.

    Kav Vedhara;Nigel Km Cox;Gordon K Wilcock;Gordon K Wilcock;Paula Perks

  • Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.

    D. M. Bowen;S. J. Allen;J. S. Benton;M. J. Goodhardt

  • Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

    C Cruchaga;CM Karch;SC Jin;BA Benitez

  • Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

    James A. R. Nicoll;Robert E. Mrak;Robert E. Mrak;David I. Graham;Janice Stewart

  • Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

    R.C.A. Pearson;M.V. Sofroniew;A.C. Cuello;T.P.S. Powell

  • Neuropathological assessment of the lesions of significance in vascular dementia.

    M M Esiri;G K Wilcock;J H Morris

  • Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

    Paul T. Francis;Alan M. Palmer;Neil R. Sims;David M. Bowen

  • Donepezil for the treatment of agitation in Alzheimer's disease

    Robert J. Howard;Edmund Juszczak;Clive G. Ballard;Peter Bentham

  • Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

    Serge Gauthier;Howard H Feldman;Lon S Schneider;Gordon K Wilcock

  • The metabolic syndrome and Alzheimer disease.

    George Razay;Anthea Vreugdenhil;Gordon Wilcock

  • The olfactory bulbs in Alzheimer's disease.

    M M Esiri;G K Wilcock

  • Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids.

    Moisés E Bauer;Kavita Vedhara;Paula Perks;Gordon K Wilcock

  • Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.

    P G Kehoe;C Russ;S McIlory;H Williams

Frequent Co-Authors

Seth Love
Seth Love University of Bristol
Margaret M. Esiri
Margaret M. Esiri University of Oxford
Bruno Vellas
Bruno Vellas Federal University of Toulouse Midi-Pyrénées
Clive Ballard
Clive Ballard University of Exeter
Giovanni B. Frisoni
Giovanni B. Frisoni University of Geneva
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Harald Hampel
Harald Hampel Eisai (United States)
Kevin Morgan
Kevin Morgan University of Nottingham
Flavio Nobili
Flavio Nobili University of Genoa
Frans R.J. Verhey
Frans R.J. Verhey Maastricht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in Medicine but want flexible and alternative career options, exploring online healthcare degrees can be a smart move. Many universities now offer accelerated and accessible nursing and advanced practice programs online, putting a rewarding career within reach for many students.

For those aiming to advance in nursing leadership, online dnp programs let you earn a Doctor of Nursing Practice degree with convenience and speed. Some students search for the most straightforward and accessible pathways, such as dnp online programs that provide flexibility for working nurses.

If you want to enter the healthcare workforce quickly, a 9 month lpn program is a fast-track route to become a Licensed Practical Nurse. Alternatively, those interested in mental health can consider specialized programs like online msn pmhnp programs to become a Psychiatric Mental Health Nurse Practitioner.

These online paths can be excellent stepping stones or alternatives to traditional medical school, and may offer faster, more affordable ways to start making a difference in healthcare.

Best Scientists Citing Gordon K. Wilcock

Trending Scientists

Recently Published Articles